Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
12/1998
12/22/1998US5851510 Hepatocyte-selective oil-in-water emulsion
12/22/1998US5851508 Compositions for use in embolizing blood vessels
12/22/1998US5851275 Water soluble pharmaceutical coating and method for producing coated pharmaceuticals
12/22/1998CA2126699C An iron-containing composition for the prevention of anaemia and a method for producing the composition
12/22/1998CA2103443C Chewable drug-delivery composition
12/17/1998WO1998056828A1 Method for manufacturing pure guar meal
12/17/1998WO1998056826A1 Ultra-fine microcrystalline cellulose compositions and process for their manufacture
12/17/1998WO1998056824A2 Incorporation of pharmacologically active amino acid analogues into proteins
12/17/1998WO1998056823A1 Induction of immune tolerance by immunotoxin
12/17/1998WO1998056717A1 Improved method for preparing low-concentration polyaluminosilicate microgels
12/17/1998WO1998056426A1 Controlled release microencapsulated ngf formulation
12/17/1998WO1998056425A1 Pharmaceutical compositions containing antibody-enzyme conjugates in combination with prodrugs
12/17/1998WO1998056424A1 Biologically active materials
12/17/1998WO1998056423A1 Novel lipid complexes for transferring at least a therapeutically active substance, in particular a polynucleotide into a target cell and use in gene therapy
12/17/1998WO1998056422A1 Polar drug or prodrug compositions with extended shelf-life storage and a method of making thereof
12/17/1998WO1998056418A1 Stabilized antibody formulation
12/17/1998WO1998056406A1 Stable insulin formulations
12/17/1998WO1998056390A1 Anthelmintic compositions
12/17/1998WO1998056387A1 Method of treatment of liver tumours and pharmaceutical compositions for use therein
12/17/1998WO1998056370A2 Therapeutic nanospheres
12/17/1998WO1998056368A1 Superiority of formulations containing coenzyme q10 in coconut oil
12/17/1998WO1998056363A1 Knobby nanospheres
12/17/1998WO1998056361A1 Drug targeting system, method of its preparation and its use
12/17/1998WO1998056360A2 Film-coated tablet for improved upper gastrointestinal tract safety
12/17/1998WO1998056355A1 Controlled release pharmaceutical preparation with ace inhibitor as active agent
12/17/1998WO1998056353A1 Internally supported lipid vesicle systems
12/17/1998WO1998056349A1 Pharmaceutical aerosol composition
12/17/1998WO1998056348A1 Compositions for delivery of biological agents and methods for the preparation thereof
12/17/1998WO1998056334A1 Compositions for delivery of biological agents and methods for the preparation thereof
12/17/1998WO1998051325A3 Random peptides that bind to gastro-intestinal tract (git) transport receptors and related methods
12/17/1998WO1998040401A3 Compositions and methods for treating infections using cationic peptides alone or in combination with antibiotics
12/17/1998WO1998040069A3 Stabilization of acid sensitive benzimidazoles with amino acid/cyclodextrin combinations
12/17/1998WO1998039467A3 Adenovirus vectors specific for cells expressing carcinoembryonic antigen and methods of use thereof
12/17/1998WO1998038983A3 Swallow tablet comprising paracetamol
12/17/1998DE19725178A1 Zusammensetzung zur Redoxkontrolle Composition for redox
12/17/1998CA2303268A1 Therapeutic nanospheres
12/17/1998CA2295013A1 Controlled release pharmaceutical preparation with ace inhibitor as active agent
12/17/1998CA2294334A1 Compositions for delivery of biological agents and methods for the preparation thereof
12/17/1998CA2293700A1 Pharmaceutical compositions containing antibody-enzyme conjugates in combination with prodrugs
12/17/1998CA2293683A1 Anthelmintic compositions
12/17/1998CA2292587A1 Ultra-fine microcrystalline cellulose compositions and process for their manufacture
12/17/1998CA2291079A1 Method for manufacturing pure guar meal
12/17/1998CA2263367A1 Novel lipid complexes for transferring at least a therapeutically active substance, in particular a polynucleotide into a target cell and use in gene therapy
12/16/1998EP0884388A1 Transgenic plants containing recombinant mistletoe lectin (rML)
12/16/1998EP0884330A1 Process for producing pure guar seed flour
12/16/1998EP0884329A1 Anti-idiotypic antibody which induces an immune response against a glycosphingolipid and use thereof
12/16/1998EP0884327A1 Dendritic lysine-based polypeptides for targeted drug delivery
12/16/1998EP0884054A2 Fixed-dose association of an angiotensin-converting enzyme inhibitor and of a calcium channel antagonist for the treatment of cardiovascular illnesses
12/16/1998EP0884053A1 Stable insulin formulations
12/16/1998EP0884052A1 Cartilage/bone inducing materials for reparation
12/16/1998EP0883993A1 Antiviral materials
12/16/1998EP0883629A1 Oligopeptides for drug delivery
12/16/1998EP0883602A2 Lipids and their use, for example, in liposomes
12/16/1998EP0883438A1 Antimicrobial compositions
12/16/1998EP0883400A1 Delivery system for localized administration of medicaments to the upper respiratory tract
12/16/1998EP0854726B1 Stable extract of hypericum perforatum l., process for preparing the same and pharmaceutical compositions
12/16/1998EP0808156B1 Compositions comprising nanoparticles of nsaid
12/16/1998EP0671942B1 Pharmaceutical preparation comprising a beta-lactam antibiotic degrading compound, and use thereof
12/16/1998EP0670714B1 Retinoic acid-containing compositions
12/16/1998CN1202110A Antibacterial composition for oral administration
12/16/1998CN1201695A Local anesthesia and improved water soluble method, neurotoxic method and local anesthetic preparation
12/16/1998CN1201692A Vaccine
12/16/1998CN1201663A Substrate for medical paste
12/15/1998US5849941 Preparation of colloidal aqueous solutions of active substances of low solubility and a lipid therefor
12/15/1998US5849860 Polyethylene-protein conjugates
12/15/1998US5849859 Polyesters
12/15/1998US5849839 Multifunctional organic polymers
12/15/1998US5849792 Storage-stable prostaglandin compositions
12/15/1998US5849729 Use of hydrolyzed cocoa butter for percutaneous absorption
12/15/1998US5849727 Compositions and methods for altering the biodistribution of biological agents
12/15/1998US5849718 Targeting complexes and use thereof
12/15/1998US5849714 Treatment of bacterial dysentery
12/15/1998US5849689 Method of extending the plasma half-life of deletion variants of hepatocyte growth factor
12/15/1998US5849580 Nucleic acid encoding a NF-κB activation regulatory protein, IκBβ
12/15/1998US5849535 Human growth hormone variants
12/15/1998US5849337 Method of enhancing magnesium absorption and prevention of atherosclerosis
12/15/1998US5849333 Delaminated transparent talc
12/15/1998US5849329 Process for preparing pharmaceutical composition having an increased active substance dissolution rate, and the compositions obtained
12/15/1998US5849308 Method of providing surfactant properties to a cosmetic or pharmaceutical composition using alkyl N-(hydroxyalkyl) carbamates
12/15/1998US5849301 Producing immunogenic constructs using soluable carbohydrates activated via organic cyanylating reagents
12/15/1998US5849297 Modified human C3 proteins
12/15/1998US5849291 Opthalmic non-irritating iodine medicament
12/15/1998US5849290 Compounds and methods for the diagnosis, treatment and prevention of diseases of cell death
12/15/1998US5849282 Method of treating colon, renal, and lung carcinomas with γ-interferon and Ser71 !-interleukin-1β
12/15/1998US5849265 Pharmaceutical aerosol formulation comprising a medicament, a propellant and a fluorinated surfactant
12/15/1998US5849263 Pharmaceutical compositions containing alkylaryl polyether alcohol polymer
12/15/1998CA2157388C Analogs for specific oligosaccharide-protein interactions and uses thereof
12/15/1998CA2149362C Pharmaceutical composition based on guar gum coated with simethicone, inassociation with a neutralizing antacid
12/15/1998CA2134677C Retinoic acid-containing compositions
12/15/1998CA2031393C Tablets with controlled-rate release of active substances
12/15/1998CA1340270C Thrombolytic composition and a process for production thereof
12/15/1998CA1340242C Liquid and pulverous preparations of fat-soluble substances and their manufacture
12/15/1998CA1340233C Antigenic epitopes of immunoglobulin e present on b cell but not basophil surface
12/15/1998CA1340199C Drug delivery systems based on hyaluronan, derivates thereof and their salts and methods of producing same
12/15/1998CA1340197C Hirudin derivatives with delayed action
12/10/1998WO1998055623A1 Type-1 ribosome-inactivating protein
12/10/1998WO1998055604A1 Hydrophilic composition containing protease produced by vibrio
12/10/1998WO1998055540A1 Process for preparing porous polyolefin particles
12/10/1998WO1998055531A2 Process for the preparation of copolyesters
12/10/1998WO1998055527A1 Biodegradable polyester urethanes, method for the production and use thereof
1 ... 1443 1444 1445 1446 1447 1448 1449 1450 1451 1452 1453 1454 1455 1456 1457 1458 1459 1460 1461 1462 1463 ... 1712